IRIS Accounts Production v25.4.0.155 04133176 Board of Directors 1.4.24 31.3.25 31.3.25 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041331762024-03-31041331762025-03-31041331762024-04-012025-03-31041331762023-03-31041331762023-04-012024-03-31041331762024-03-3104133176ns15:EnglandWales2024-04-012025-03-3104133176ns14:PoundSterling2024-04-012025-03-3104133176ns10:Director12024-04-012025-03-3104133176ns10:CompanyLimitedByGuarantee2024-04-012025-03-3104133176ns10:SmallEntities2024-04-012025-03-3104133176ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3104133176ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3104133176ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3104133176ns10:FullAccounts2024-04-012025-03-3104133176ns10:Director22024-04-012025-03-3104133176ns10:Director32024-04-012025-03-3104133176ns10:Director42024-04-012025-03-3104133176ns10:Director62024-04-012025-03-3104133176ns10:Director72024-04-012025-03-3104133176ns10:Director82024-04-012025-03-3104133176ns10:Director92024-04-012025-03-3104133176ns10:RegisteredOffice2024-04-012025-03-3104133176ns5:CurrentFinancialInstruments2025-03-3104133176ns5:CurrentFinancialInstruments2024-03-3104133176ns5:RetainedEarningsAccumulatedLosses2025-03-3104133176ns5:RetainedEarningsAccumulatedLosses2024-03-3104133176ns5:PlantMachinery2024-04-012025-03-3104133176ns5:PlantMachinery2024-03-3104133176ns5:ComputerEquipment2024-03-3104133176ns5:PlantMachinery2025-03-3104133176ns5:ComputerEquipment2025-03-3104133176ns5:PlantMachinery2024-03-3104133176ns5:ComputerEquipment2024-03-3104133176ns5:CostValuation2024-03-3104133176ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3104133176ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31
REGISTERED NUMBER: 04133176 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: RH Sammons
MR Bending
M E C Dockrell
Dr M Phanish
Professor R G Price
S Simper
Dr S L Hyer
Professor D L Baines





REGISTERED OFFICE: The Renal Unit
St Helier Hospital
Wrythe Lane
Carshalton
Surrey
SM5 1AA





REGISTERED NUMBER: 04133176 (England and Wales)





ACCOUNTANTS: GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH1 6RW

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - -
Investments 5 9,510 9,510
9,510 9,510

CURRENT ASSETS
Debtors 6 15,536 12,865
Cash at bank 104,278 70,920
119,814 83,785
CREDITORS
Amounts falling due within one year 7 19,426 26,679
NET CURRENT ASSETS 100,388 57,106
TOTAL ASSETS LESS CURRENT
LIABILITIES

109,898

66,616

RESERVES
Income and expenditure account 109,898 66,616
109,898 66,616

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 December 2025 and were signed on its behalf by:





Dr M Phanish - Director


SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

South West Thames Institute for Renal Research is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover comprises net amounts invoiced in respect of research contracts (excluding value added tax) together with voluntary income from donations and grants received or due in relation to expenses incurred in the year. Any amounts received in advance are carried forward as deferred income to the following year.


Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 April 2024
and 31 March 2025 265,601 17,819 283,420
DEPRECIATION
At 1 April 2024
and 31 March 2025 265,601 17,819 283,420
NET BOOK VALUE
At 31 March 2025 - - -
At 31 March 2024 - - -

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


5. FIXED ASSET INVESTMENTS
Other
investment
£   
COST
At 1 April 2024
and 31 March 2025 9,510
NET BOOK VALUE
At 31 March 2025 9,510
At 31 March 2024 9,510

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 15,536 12,865

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 4,175 13,786
Taxation and social security 8,657 -
Other creditors 6,594 12,893
19,426 26,679

8. LIMITED BY GUARANTEE

South West Thames Institute for Renal Research is a non-profit making company limited by guarantee and has no share capital.